Searched for
LIMBASI
Concord Biotech's niche API play holds promise for growthET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than ...- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Concord Biotech, Vaibhav Gems get Sebi's approval to float IPOsThe company is backed by Quadria Capital Fund and Rare Enterprises, which was set up by billionaire investor Rakesh Jhunjhunwala, along wit...
- Load More